Failure to Monitor Insulin and IV Antibiotic Therapy
Summary
The facility failed to monitor two residents for signs and symptoms of hypoglycemia and hyperglycemia while they were receiving insulin therapy, and failed to monitor one resident for side effects while receiving two IV antibiotics. Resident 5 had diagnoses including metabolic encephalopathy, type II DM, and CKD, and his MDS indicated moderately impaired cognitive skills and extensive assistance needs with daily care. His physician orders included Insulin Glargine daily and Insulin Aspart before meals with sliding-scale coverage, and the care plan directed staff to observe for signs and symptoms of hypoglycemia and hyperglycemia. During interview and record review, the RN supervisor stated there were no orders for monitoring these signs and symptoms and no documentation showing that staff monitored the resident or followed the care plan. Resident 12 had diagnoses including an MRSA wound of the right foot, type II DM with hyperglycemia, cellulitis, and gangrene of the right lower extremity, and the MDS indicated severely impaired cognitive skills and dependence for most activities of daily living. The physician orders included Insulin Glargine every 12 hours and Insulin Lispro before meals with sliding-scale coverage. The care plan directed staff to monitor for signs and symptoms of hypoglycemia and hyperglycemia, but the IPN and RN stated there was no documentation that this monitoring occurred and no monitoring order was present. They stated that without documentation, the monitoring was not shown to have been done. Resident 12 also had physician orders for Ceftriaxone Sodium and Vancomycin HCl for the MRSA wound. The care plan for risk of side effects related to these antibiotics directed staff to administer the IV antibiotics separately, flush the lines before and after administration, and monitor for side effects such as hives, shortness of breath, diarrhea, or DRESS syndrome. The IPN and RN stated there was no documentation that the resident was monitored for antibiotic side effects, and the RN stated the side effects of the two antibiotics should have been monitored specifically for each medication.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.